Gladstone NOW: The Campaign Join Us on the Journey ✕
31 - 45 of 46 Results Clear All
Study finds blood protein destroys memory storage sites in the brain and may lead to new treatments
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Akassoglou Lab Aging
Katerina Akassoglou is selected as the 2018 recipient of the Barancik Prize for Innovation in Multiple Sclerosis Research
Awards Multiple Sclerosis Neurological Disease Akassoglou Lab
Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks
News Release Research (Publication) Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab
Study may lead to new treatments for diseases like multiple sclerosis
Akassoglou Lab Multiple Sclerosis
The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.
Multiple Sclerosis Akassoglou Lab
Katerina Akassoglou is calling for a fundamental change in the way scientists approach neurological disorders. Her research on the brain’s vascular and immune systems has led to new insights about multiple sclerosis and other conditions.
Multiple Sclerosis Akassoglou Lab
The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.
Neurological Disease Akassoglou Lab
Scientists at the Gladstone Institutes have discovered an unusual regulator of body weight and the metabolic syndrome: a molecular mechanism more commonly associated with brain cells.
Diabetes Neurological Disease Akassoglou Lab Basic Science Metabolism
A new study from the Gladstone Institutes shows that a single drop of blood in the brain is sufficient to activate an autoimmune response akin to multiple sclerosis (MS).
Akassoglou Lab Multiple Sclerosis
Victoria Rafalski, a postdoctoral scholar in the Akassoglou lab, encourages young scientists to pursue a career that aligns with their personal values.
Akassoglou Lab
Katerina Akassoglou is working to identify a biomarker that could track the progression of multiple sclerosis using blood tests
Akassoglou Lab Multiple Sclerosis
SAN FRANCISCO, CA—For some, the disease multiple sclerosis (MS) attacks its victims slowly and progressively over a period of many years. For others, it strikes without warning in fits and starts.
Akassoglou Lab Neurological Disease Multiple Sclerosis
SAN FRANCISCO, CA—Inside each of us is our own internal timing device. It drives everything from sleep cycles to metabolism, but the inner-workings of this so-called “circadian clock” are complex, and the molecular processes behind it have long eluded scientists.
Akassoglou Lab Metabolism
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)—a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord.
Akassoglou Lab Multiple Sclerosis
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have discovered a key protein that regulates insulin resistance—the diminished ability of cells to respond to the action of insulin and which sets the stage for the development of the most common form of diabetes.
Akassoglou Lab Diabetes Metabolism
